Immuron
Open
$0.81
Prev. Close
$0.81
High
$0.81
Low
$0.81
Market Snapshot
$4.73M
-2.89
$19.65M
7
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.
emptyResult
Immuron Ltd. is a biopharmaceutical company, which focuses on the development and commercialization of a novel class of specifically targeted polyclonal antibodies. The company operates through two segments: Research and development (R&D), and Hyperimmune products. The R&D segment is focused on R&D projects performed in Australia and the United States. Hyperimmune products segment is engaged in Travelan and Protectyn activities which occur predominantly in Australia, the United States and Canada. Its flagship products consist of Travelan and Protectyn. Travelan is an orally administered passive immunotherapy that prophylactically reduces the likelihood of contracting traveler’s diarrhea and is sold in pharmacies throughout Australia. Protectyn is sold online and in health practitioner clinics and is marketed as an immune supplement to help maintain a healthy digestive function and liver. Its clinical programs include Travelan (IMM-124E), IMM-529, and CampETEC.
Recently from Cashu
Immuron Advances Gut Health Research with Innovative Therapeutics and Collaborations
Immuron Advances Therapeutic Research in Gut Health Immuron, a biopharmaceutical company specializing in gut health, announces significant progress in its research and development efforts focused on i…
Request for Content on Immuron for Summary Assistance
I apologize, but it seems there is no content provided for summarization. If you could share specific details or key points about Immuron or any relevant developments in their industry, I would be gla…
Immuron Stock Summary: Key Insights and Updates on Company Performance and Developments.
I apologize, but I need the specific content that you would like summarized in order to assist you effectively. Please provide the text, and I will help you create a summary as requested.
Immuron Stock: Summary Request for Content Review and Analysis
I apologize, but it seems you haven't provided the text that you'd like me to summarize. Please share the content, and I'll be happy to help you create a 300-word summary that includes the company nam…